<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03286452</url>
  </required_header>
  <id_info>
    <org_study_id>16-REG-002-PPAM</org_study_id>
    <nct_id>NCT03286452</nct_id>
  </id_info>
  <brief_title>The RESPOND Registry</brief_title>
  <acronym>RESPOND</acronym>
  <official_title>Real-World Effectiveness Study of PuraPly™ AM on Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Organogenesis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Continuum Clinical Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Organogenesis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The RESPOND Registry is an observational study to assess the impact of PuraPly™ AM on the
      management of wounds in real world clinical settings; no experimental intervention is
      involved.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to assess the impact of PuraPly™ AM on the management of wounds
      in real world clinical settings as it leads to an improvement in wound bed condition (i.e
      increase in healthy granulation tissue, reduction in bioburden, and reduction in amount of
      exudate).

      The RESPOND Registry is a prospective, non-interventional research initiative to collect
      information on patients who are eligible to receive PuraPly™ AM, and no interventional
      procedures will be mandated by this protocol.

      Enrolled and eligible patients will receive standard wound care clinical assessments and any
      additional care as determined by the treating wound care clinician. Although multiple wounds
      may be treated simultaneously, one wound will be identified as the target wound, and
      characteristics regarding this wound will be consistently documented.

      The case series is being undertaken to better understand PuraPly™ AM utilization and
      subsequent healing outcomes as well as to evaluate the effects of concomitant wound therapy
      on healing. Patient's participation may involve follow-up for up to 24 weeks following
      application of PuraPly™ AM.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Weeks</target_duration>
  <primary_outcome>
    <measure>Reduction in size of wound area</measure>
    <time_frame>Up to 24 weeks</time_frame>
    <description>As measured from change in size from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to complete wound closure</measure>
    <time_frame>Up to 24 weeks</time_frame>
    <description>As measured by time to complete wound closure from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in wound bed condition</measure>
    <time_frame>Up to 24 weeks</time_frame>
    <description>As measured from change in status from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in patient reported pain</measure>
    <time_frame>Up to 24 weeks</time_frame>
    <description>As measured change in status from baseline as assessed by the PAIN visual analogue scale (PAIN-VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in patient reported quality of life</measure>
    <time_frame>Up to 24 weeks</time_frame>
    <description>As measured by change in status from baseline as assessed by the SF-12 QoL.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Partial Thickness Wound</condition>
  <condition>Pressure Ulcer</condition>
  <condition>Venous Ulcer</condition>
  <condition>Diabetic Ulcer</condition>
  <condition>Surgical Wounds</condition>
  <condition>Trauma Wounds</condition>
  <condition>Draining Wounds</condition>
  <condition>Chronic Vascular Ulcer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PuraPly™ Antimicrobial Wound Matrix</intervention_name>
    <description>PuraPly™ Antimicrobial Wound Matrix consists of a collagen sheet coated with 0.1% polyhexamethylenebiguanide hydrochloride (PHMB) intended for the management of wounds.</description>
    <other_name>PuraPly™ Antimicrobial</other_name>
    <other_name>PuraPly™ AM</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Approximately 300 patients to be enrolled by approximately 30 US-based Physician
        Investigators. Patients are male or female at least 18 years old, with an eligible target
        wound that meets the Investigator's wound specific treatment goals; including the
        management of bioburden, support of granulation tissue formation, and support of wound
        closure.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is at least 18 years of age.

          -  Patient, or their legally authorized representative (LAR), has read, understood and
             signed and Institutional Review Board (IRB) approved Informed Consent Form (ICF).

          -  Patient has a wound appropriate for receiving PuraPly™ AM, including:

               -  Partial or full-thickness wound

               -  Pressure ulcer

               -  Venous ulcer

               -  Diabetic ulcer

               -  Chronic vascular ulcer

               -  Tunneled/undermined wound

               -  Surgical wound (e.g., donor sites/graft, post-Mohs' surgery, post-laser surgery,
                  podiatric surgery wound, wound dehiscence)

               -  Trauma wound (abrasions, lacerations, second degree burns, and skin tears)

               -  Draining wound

        Exclusion Criteria:

          -  Patient has a known sensitivity to porcine materials.

          -  Patient has a third-degree burn.

          -  Patient has a known sensitivity to polyhexamethylenebiguanide hydrochloride (PHMB).

          -  Patient's target wound was previously treated with PuraPly™ AM.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam J Teichman, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>PA Foot and Ankle Association</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shaun Carpenter, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wound Care Associates, LLC.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel L Kapp, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jupiter Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kerry Thibodeaux, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Opelousas General Hospital Wound Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>George Koullias, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southampton Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raymond Abdo, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Louis Foot and Ankle</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barry Wisler, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Robert Wood Johnson Hamilton</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Trabanco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>West Gables Rehabilitation Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ifat Kamin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meriter Hospital Inc., DBA: UnityPoint Health Heart and Vascular Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amanda Estapa, NP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Advanced Wound Healing; Northshore Specialty Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Menack, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CentraState Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ritu Gothwal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Advanced Wound Care Center at Yavapai Regional Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Iafrati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paula Pons, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Joseph's Center for Wound Care and Hyperbaric Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Taysha Howell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma Wound Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Allan Grossman, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harrisburg Foot and Ankle Center, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick Bilbo</last_name>
    <phone>+1 (781) 575-0775</phone>
    <email>PBilbo@organo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Santina Wendling</last_name>
    <phone>781-401-1147</phone>
    <email>Wendling@Organo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Advanced Wound Care Center at Yavapai Regional Medical Center</name>
      <address>
        <city>Prescott Valley</city>
        <state>Arizona</state>
        <zip>86314</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ritu Gothwal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jupiter Medical Center</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Daniel L Kapp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Gables Rehab Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Carlos Trabanco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute for Advanced Wound Healing; Northshore Specialty Hospital</name>
      <address>
        <city>Covington</city>
        <state>Louisiana</state>
        <zip>70433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Amanda Estapa, NP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wound Care Associates, LLC.</name>
      <address>
        <city>Hammond</city>
        <state>Louisiana</state>
        <zip>70403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Shaun Carpenter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Opelousas General Hospital Wound Center</name>
      <address>
        <city>Opelousas</city>
        <state>Louisiana</state>
        <zip>70570</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kerry Thibodeaux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Louis Foot and Ankle</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Raymond Abdo, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CentraState Medical Center</name>
      <address>
        <city>Freehold</city>
        <state>New Jersey</state>
        <zip>07728</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michael Menack, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Robert Wood Johnson Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>New Jersey</state>
        <zip>08690</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Barry Wisler, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southampton Hospital</name>
      <address>
        <city>Southampton</city>
        <state>New York</state>
        <zip>11968</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>George Kouillas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wayne Memorial Hospital</name>
      <address>
        <city>Goldsboro</city>
        <state>North Carolina</state>
        <zip>27534</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dimitrios Lintzeris, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sacred Heart Hospital</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Adam J Teichman, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harrisburg Foot and Ankle Center, Inc.</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Allan Grossman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greensville Health System</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ryan Fitzgerald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meriter Hospital Inc., DBA: UnityPoint Health Heart and Vascular Institute</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ifat Kamin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2017</study_first_submitted>
  <study_first_submitted_qc>September 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2017</study_first_posted>
  <last_update_submitted>September 15, 2017</last_update_submitted>
  <last_update_submitted_qc>September 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Antimicrobial</keyword>
  <keyword>Collagen</keyword>
  <keyword>Bioburden</keyword>
  <keyword>Biofilm</keyword>
  <keyword>PHMB</keyword>
  <keyword>Chronic wounds</keyword>
  <keyword>Acute wounds</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Pressure Ulcer</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

